Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on December 26, 2006

Circulation. 2006
Published online before print December 26, 2006, doi: 10.1161/CIRCULATIONAHA.106.640698
A more recent version of this article appeared on January 2, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
115/1/67    most recent
CIRCULATIONAHA.106.640698v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kapur, N. K.
Right arrow Articles by Rade, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kapur, N. K.
Right arrow Articles by Rade, J. J.
Related Collections
Right arrow Congestive
Right arrow Arterial thrombosis
Right arrow Thrombin
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Embolic stroke
Right arrow Physiological and pathological control of gene expression

Submitted on April 3, 2006
Accepted on October 13, 2006

Hemodynamic Modulation of Endocardial Thromboresistance

Navin K. Kapur MD, Clayton B. Deming MS, Sunil Kapur BS, Ce Bian MD, Hunter C. Champion MD, PhD, J. Kevin Donahue MD, David A. Kass MD, and Jeffrey J. Rade MD*

From the Department of Medicine, Division of Cardiology of the Johns Hopkins School of Medicine, Baltimore, Md.

* To whom correspondence should be addressed. E-mail: jjrade{at}jhmi.edu.

Background--Patients with heart failure are at increased risk for thromboembolic events, including stroke. Historically attributed to blood stasis, little is known about the adverse effects of elevated chamber filling pressure on endocardial function, which could predispose to intracardiac thrombus formation.

Methods and Results--We investigated changes in the expression of thrombomodulin, a key component of the anticoagulant protein C pathway, in rats subjected to acute atrial pressure overload caused by aortic banding. Acute elevation of left atrial filling pressure, without an associated decline in ventricular systolic function, caused a 70% inhibition of atrial endocardial thrombomodulin expression and resulted in increased local thrombin generation. Targeted restoration of atrial thrombomodulin expression with adenovirus-mediated gene transfer successfully reduced thrombin generation to baseline levels. In vitro co-culture studies revealed that thrombomodulin downregulation is caused by the paracrine release of transforming growth factor-{beta} from cardiac connective tissue in response to mechanical stretch. This was confirmed in vivo by administration of a neutralizing transforming growth factor-{beta} antibody, which effectively prevented thrombomodulin downregulation during acute pressure overload.

Conclusions--These findings suggest that increased hemodynamic load adversely affects endocardial function and is a potentially important contributor to thromboembolus formation in heart failure.


Key words: endocardium • heart failure • thrombosis • thrombomodulin